These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23337595)

  • 41. Vaccines-all things considered. Part II. 2-3 December 2004, San Francisco, CA, USA.
    Rosenthal KS
    IDrugs; 2005 Feb; 8(2):110-1. PubMed ID: 15696409
    [No Abstract]   [Full Text] [Related]  

  • 42. Omic techniques in systems biology approaches to traditional Chinese medicine research: present and future.
    Buriani A; Garcia-Bermejo ML; Bosisio E; Xu Q; Li H; Dong X; Simmonds MS; Carrara M; Tejedor N; Lucio-Cazana J; Hylands PJ
    J Ethnopharmacol; 2012 Apr; 140(3):535-44. PubMed ID: 22342380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plant-made pharmaceuticals for the prevention and treatment of autoimmune diseases: where are we?
    Avesani L; Bortesi L; Santi L; Falorni A; Pezzotti M
    Expert Rev Vaccines; 2010 Aug; 9(8):957-69. PubMed ID: 20673017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Precipitation as an Enabling Technology for the Intensification of Biopharmaceutical Manufacture.
    Martinez M; Spitali M; Norrant EL; Bracewell DG
    Trends Biotechnol; 2019 Mar; 37(3):237-241. PubMed ID: 30316558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patho-biotechnology: using bad bugs to do good things.
    Sleator RD; Hill C
    Curr Opin Biotechnol; 2006 Apr; 17(2):211-6. PubMed ID: 16459072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Society for Biomolecular Sciences--15th Annual Conference. Bioassay and technology innovation: 15 years of shaping drug discovery. 26-30 April 2009, Lille, France.
    Napper AD
    IDrugs; 2009 Jun; 12(6):363-5. PubMed ID: 19517316
    [No Abstract]   [Full Text] [Related]  

  • 48. Combined proteomic technology in landmark study encourages advancement in personalized multiple myeloma treatment.
    Miller S
    Expert Rev Proteomics; 2011 Dec; 8(6):685. PubMed ID: 22087653
    [No Abstract]   [Full Text] [Related]  

  • 49. The future of industrial bioprocessing: batch or continuous?
    Croughan MS; Konstantinov KB; Cooney C
    Biotechnol Bioeng; 2015 Apr; 112(4):648-51. PubMed ID: 25694022
    [No Abstract]   [Full Text] [Related]  

  • 50. Placing bets on biotech.
    Weintraub K
    Cancer Discov; 2011 Nov; 1(6):462. PubMed ID: 22586641
    [No Abstract]   [Full Text] [Related]  

  • 51. Non-parenteral vaccines.
    Po AL
    BMJ; 2004 Jul; 329(7457):62-3. PubMed ID: 15242884
    [No Abstract]   [Full Text] [Related]  

  • 52. Personalized medicine: a personal view.
    Meyer UA
    Clin Pharmacol Ther; 2012 Mar; 91(3):373-5. PubMed ID: 22343810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Information technologies for vaccine research.
    Brusic V; August JT; Petrovsky N
    Expert Rev Vaccines; 2005 Jun; 4(3):407-17. PubMed ID: 16026252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical potential and challenges of sequencing cancer genomes for personalized medical genomics.
    Cloonan N; Waddell N; Grimmond SM
    IDrugs; 2010 Nov; 13(11):778-81. PubMed ID: 21046525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Personalized medicine policy challenges: measuring clinical utility at point of care.
    van Rooij T; Wilson DM; Marsh S
    Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):289-95. PubMed ID: 22812553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of the near-infrared spectroscopy in the pharmaceutical technology.
    Jamrógiewicz M
    J Pharm Biomed Anal; 2012 Jul; 66():1-10. PubMed ID: 22469433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deal watch: Trends in platform technology deal-making.
    Walker J; Jacob J
    Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
    [No Abstract]   [Full Text] [Related]  

  • 58. Drug evaluation: CYT-002-NicQb, a therapeutic vaccine for the treatment of nicotine addiction.
    Heading CE
    Curr Opin Investig Drugs; 2007 Jan; 8(1):71-7. PubMed ID: 17263188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery and development of biopharmaceuticals: current issues.
    Strohl WR; Knight DM
    Curr Opin Biotechnol; 2009 Dec; 20(6):668-72. PubMed ID: 19896824
    [No Abstract]   [Full Text] [Related]  

  • 60. The optimum time for drug licensing.
    Kalamas J; Pinkus G
    Nat Rev Drug Discov; 2003 Sep; 2(9):691-2. PubMed ID: 12953694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.